Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Emma Guttman
Icahn School of Medicine at Mount Sinai, Department: Dermatology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Pfizer
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Emma Guttman (the Principal Investigator in this study) receives financial compensation as an advisory board member and lecturer for Pfizer (manufacturer of the study drug ILV-094). Dr. Guttman's spouse receives financial compensation as an advisory board member for Pfizer.
A Study of ILV-94 (Anti-22 Antibody) Administered via IV in Atopic Dermatitis
Public Health Relevance: There is a strong need for effective long-term treatments for atopic dermatitis (AD), and this study may lead to such a therapy. Our study will be the first to explore the effects of blocking IL-22 in AD. IL-22 is a potential key cytokine in AD and inhibiting it may provide significant advantages over other available treatments, including: a selective target and potential safety advantages compared to broad immune suppressants.
Filed on June 21, 2016.
Tell us what you know about Emma Guttman's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.